The lung in the antiphospholipid syndrome

A. A. Demin, N. N. Chapaeva (Novosibirsk, Russia)

Source: Annual Congress 2004 - Clinical pathobiology of interstitial lung diseases
Session: Clinical pathobiology of interstitial lung diseases
Session type: Thematic Poster Session
Number: 3329
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. A. Demin, N. N. Chapaeva (Novosibirsk, Russia). The lung in the antiphospholipid syndrome. Eur Respir J 2004; 24: Suppl. 48, 3329

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary involvement in antiphospholipid syndrome
Source: Eur Respir Monogr 2019; 86: 124-139
Year: 2019


Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Source: Eur Respir J 2008; 32: 244-245
Year: 2008


Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus
Source: Eur Respir J 2008; 31: 213-217
Year: 2008



Lung complications of Sjogren syndrome
Source: Eur Respir Rev, 29 (157) 200021; 10.1183/16000617.0021-2020
Year: 2020



Pulmonary involvement in antisynthetase syndrome: more than myopathy
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021


Hypereosinophilic syndromes and lung involvement
Source: Eur Respir Monogr 2022; 95: 153-176
Year: 2022


1 year evolution of pulmonary hypertension in patients with connective tissue diseases and secondary antiphospholipid syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 280s
Year: 2004

Pulmonary findings of the patients with Sjogren syndrome
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012


Pulmonary manifestations of antiphospholipid syndrome: A retrospective analysis of 67 patients
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018



Primary antiphospholipid antibody syndrome with pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 247s
Year: 2004

Interstitial lung disease in Sjogren's syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 587s
Year: 2002

The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension
Source: Eur Respir Monogr 2019; 86: 262-277
Year: 2019


Pulmonary involvement in patients with Marfan syndrome
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012

A case of antiphospholipid antibody syndrome became pregnant under warfarin treatment
Source: Annual Congress 2007 - Venous thromboembolism
Year: 2007


Hepatopulmonary syndrome in children with chronic liver disease
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005

Lung cancer and paraneoplastic syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Non-infectious pulmonary involvement in myelodysplastic syndrome
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008

Etanercept-induced pleuropericardial lupus-like syndrome
Source: Eur Respir J 2009; 33: 939-941
Year: 2009


Pulmonary involvement in Marfan syndrome
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018